Effectiveness of influenza vaccine in aging and older adults: Comprehensive analysis of the evidence

Pierre Olivier Lang, Aline Mendes, Jennifer Socquet, Noémie Assir, Sheila Govind, Richard Aspinall

Research output: Contribution to journalReview article

56 Citations (Scopus)
7 Downloads (Pure)

Abstract

Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals. Immunization is considered to be the cornerstone for preventing these adverse health outcomes, and vaccination programs are timed to optimize protection during the annual influenza season. Trivalent inactivated influenza virus vaccines are believed to be both effective and cost-saving; however, in spite of widespread influenza vaccination programs, rates of hospitalization for acute respiratory illness and cardiovascular diseases have been increasing in this population during recent annual influenza seasons. From meta-analyses summarizing estimates of influenza vaccine effectiveness from available observational clinical studies, this review aims to examine how effective current influenza vaccine strategies are in the aging and older adult population and to analyze which are the most important biases that interfere with measurements of influenza vaccine effectiveness. Furthermore, consideration is given to strategies that should be adopted in order to optimize influenza vaccine effectiveness in the face of immune exhaustion.

Original languageEnglish
Pages (from-to)55-64
Number of pages10
JournalClinical Interventions in Aging
Volume7
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Influenza Vaccines
Human Influenza
Vaccination
Hospitalization
Inactivated Vaccines
Virus Diseases
Orthomyxoviridae
Population
Observational Studies
Meta-Analysis
Immunization
Cardiovascular Diseases
Costs and Cost Analysis
Health

Keywords

  • Hemagglutinin activity inhibition
  • Hemagglutinin inhibition
  • Immunosenescence
  • Influenza vaccine effectiveness
  • Influenza virus infection
  • Innate immunity
  • Older adults

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Effectiveness of influenza vaccine in aging and older adults : Comprehensive analysis of the evidence. / Lang, Pierre Olivier; Mendes, Aline; Socquet, Jennifer; Assir, Noémie; Govind, Sheila; Aspinall, Richard.

In: Clinical Interventions in Aging, Vol. 7, 2012, p. 55-64.

Research output: Contribution to journalReview article

Lang, Pierre Olivier ; Mendes, Aline ; Socquet, Jennifer ; Assir, Noémie ; Govind, Sheila ; Aspinall, Richard. / Effectiveness of influenza vaccine in aging and older adults : Comprehensive analysis of the evidence. In: Clinical Interventions in Aging. 2012 ; Vol. 7. pp. 55-64.
@article{bc78ed183cfb44e3bec684f6508e1e58,
title = "Effectiveness of influenza vaccine in aging and older adults: Comprehensive analysis of the evidence",
abstract = "Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals. Immunization is considered to be the cornerstone for preventing these adverse health outcomes, and vaccination programs are timed to optimize protection during the annual influenza season. Trivalent inactivated influenza virus vaccines are believed to be both effective and cost-saving; however, in spite of widespread influenza vaccination programs, rates of hospitalization for acute respiratory illness and cardiovascular diseases have been increasing in this population during recent annual influenza seasons. From meta-analyses summarizing estimates of influenza vaccine effectiveness from available observational clinical studies, this review aims to examine how effective current influenza vaccine strategies are in the aging and older adult population and to analyze which are the most important biases that interfere with measurements of influenza vaccine effectiveness. Furthermore, consideration is given to strategies that should be adopted in order to optimize influenza vaccine effectiveness in the face of immune exhaustion.",
keywords = "Hemagglutinin activity inhibition, Hemagglutinin inhibition, Immunosenescence, Influenza vaccine effectiveness, Influenza virus infection, Innate immunity, Older adults",
author = "Lang, {Pierre Olivier} and Aline Mendes and Jennifer Socquet and No{\'e}mie Assir and Sheila Govind and Richard Aspinall",
year = "2012",
doi = "10.2147/CIA.S25215",
language = "English",
volume = "7",
pages = "55--64",
journal = "Clinical Interventions in Aging",
issn = "1176-9092",
publisher = "Dove Medical Press",

}

TY - JOUR

T1 - Effectiveness of influenza vaccine in aging and older adults

T2 - Comprehensive analysis of the evidence

AU - Lang, Pierre Olivier

AU - Mendes, Aline

AU - Socquet, Jennifer

AU - Assir, Noémie

AU - Govind, Sheila

AU - Aspinall, Richard

PY - 2012

Y1 - 2012

N2 - Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals. Immunization is considered to be the cornerstone for preventing these adverse health outcomes, and vaccination programs are timed to optimize protection during the annual influenza season. Trivalent inactivated influenza virus vaccines are believed to be both effective and cost-saving; however, in spite of widespread influenza vaccination programs, rates of hospitalization for acute respiratory illness and cardiovascular diseases have been increasing in this population during recent annual influenza seasons. From meta-analyses summarizing estimates of influenza vaccine effectiveness from available observational clinical studies, this review aims to examine how effective current influenza vaccine strategies are in the aging and older adult population and to analyze which are the most important biases that interfere with measurements of influenza vaccine effectiveness. Furthermore, consideration is given to strategies that should be adopted in order to optimize influenza vaccine effectiveness in the face of immune exhaustion.

AB - Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals. Immunization is considered to be the cornerstone for preventing these adverse health outcomes, and vaccination programs are timed to optimize protection during the annual influenza season. Trivalent inactivated influenza virus vaccines are believed to be both effective and cost-saving; however, in spite of widespread influenza vaccination programs, rates of hospitalization for acute respiratory illness and cardiovascular diseases have been increasing in this population during recent annual influenza seasons. From meta-analyses summarizing estimates of influenza vaccine effectiveness from available observational clinical studies, this review aims to examine how effective current influenza vaccine strategies are in the aging and older adult population and to analyze which are the most important biases that interfere with measurements of influenza vaccine effectiveness. Furthermore, consideration is given to strategies that should be adopted in order to optimize influenza vaccine effectiveness in the face of immune exhaustion.

KW - Hemagglutinin activity inhibition

KW - Hemagglutinin inhibition

KW - Immunosenescence

KW - Influenza vaccine effectiveness

KW - Influenza virus infection

KW - Innate immunity

KW - Older adults

UR - http://www.scopus.com/inward/record.url?scp=84861957178&partnerID=8YFLogxK

U2 - 10.2147/CIA.S25215

DO - 10.2147/CIA.S25215

M3 - Review article

VL - 7

SP - 55

EP - 64

JO - Clinical Interventions in Aging

JF - Clinical Interventions in Aging

SN - 1176-9092

ER -